CRESP DARBEPOETIN ALFA  INJECTION
CRESP DARBEPOETIN ALFA  INJECTION

CRESP DARBEPOETIN ALFA INJECTION

CRESP DARBEPOETIN ALFA INJECTION Specification

  • Dosage Form
  • Injection
  • Origin
  • Biotechnology/Genetically Engineered
  • Salt Composition
  • Darbepoetin Alfa
  • Indication
  • Treatment of anemia in chronic kidney disease and chemotherapy induced anemia
  • Ingredients
  • Darbepoetin Alfa, excipients
  • Application
  • Increases red blood cell production
  • Ph Level
  • Approximately neutral (6.07.0)
  • Physical Color/Texture
  • Clear, colorless and aqueous solution
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store at 2C to 8C, do not freeze, protect from light
  • Shelf Life
  • 24 months from the date of manufacture
 

CRESP DARBEPOETIN ALFA INJECTION Trade Information

  • Packaging Details
  • PACK OF 1 VIAL
  • Main Domestic Market
  • All India
 

About CRESP DARBEPOETIN ALFA INJECTION

Cresp is manufactured By Dr. Reddys. Cresp contains Darbepoetin alfa injection.


Cresp is the world first generic version of darbepoetin alpha in the world and the only darbepoetin alfa in India. Darbepoetin alfa is a modified version of epoetin alfa, which is engineered to have a longer half life, increasing (up to 3 times) the time it remains in the blood. This results in a reduced frequency of doses, providing a simpler and more convenient treatment option for patients and physicians as compared to treatment of anaemia with epoetin which is the current standard of care in India...........

Other Information

  • Minimum Order Quantity: 1
  • Port of Dispatch: New Delhi, India

Specification

  • Drug:CRESP 100MG
  • Usage:Hospital
  • Brand:DR. REDDYS
  • Form:INJECTION
  • Packaging Type:INJECTION
  • Dose/Strength:25



How CRESP Darbepoetin Alfa Injection Works

Cresp contains genetically engineered Darbepoetin Alfa, designed to stimulate your bodys bone marrow to produce more red blood cells. This action helps alleviate anemia caused by chronic kidney disease or chemotherapy treatments, ultimately improving oxygen circulation and reducing fatigue in affected individuals.


Proper Administration of CRESP Injection

The injection can be administered subcutaneously or intravenously, depending on your doctors recommendation. It is crucial that only trained healthcare professionals carry out the process. CRESP should never be combined with other drugs in the same syringe to maintain compatibility and prevent adverse reactions.


Safety Measures and Storage Guidelines

Store CRESP Darbepoetin Alfa Injection between 2C and 8C, and ensure the solution is protected from light and not frozen. Patients with uncontrolled hypertension or known allergies should use this medicine with caution and under close medical supervision to avoid complications.

FAQs of CRESP DARBEPOETIN ALFA INJECTION:


Q: How should CRESP Darbepoetin Alfa Injection be administered?

A: CRESP Darbepoetin Alfa Injection is administered either subcutaneously (under the skin) or intravenously (into a vein), as prescribed by your healthcare provider. Only trained professionals should handle its administration to ensure correct dosage and technique.

Q: What is the primary benefit of using CRESP Darbepoetin Alfa Injection?

A: The main benefit is the treatment of anemia due to chronic kidney disease or chemotherapy. It increases the production of red blood cells, helping to raise hemoglobin levels and reduce symptoms such as fatigue and weakness.

Q: When should CRESP Darbepoetin Alfa Injection be used with caution?

A: You should use CRESP with caution if you have uncontrolled hypertension or a known hypersensitivity to its ingredients. Your doctor will carefully assess your eligibility before prescribing this medication.

Q: Where should CRESP Darbepoetin Alfa Injection be stored, and what precautions should be taken?

A: CRESP should be stored at a temperature between 2C and 8C, protected from light, and must not be frozen. Follow all storage instructions to maintain the medications effectiveness and safety.

Q: What should be avoided when preparing CRESP Darbepoetin Alfa Injection?

A: Do not mix CRESP with any other drugs in the same syringe, as it is not compatible and may result in harmful reactions. Always use a dedicated syringe as directed by your healthcare provider.

Q: Who should prescribe and administer CRESP Darbepoetin Alfa Injection?

A: Only licensed medical professionals should prescribe and administer CRESP Darbepoetin Alfa Injection, given its specific indications, prescription status, and the need for proper handling.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anticancer Medicines Category

ERLONAT ERLOTINIB TABLETS

ERLONAT ERLOTINIB TABLETS

Minimum Order Quantity : 100 Boxes

Dosage Form : Tablets

Feature : Other

Shelf Life : 36 Months

Ingredients : Other

Application : Other, Anticancer Medication

MYEZOM BORTEZOMIB 3.5 MG INJECTION

MYEZOM BORTEZOMIB 3.5 MG INJECTION

Dosage Form : Injection

Feature : Other, Antineoplastic agent; administered intravenously or subcutaneously

Shelf Life : 24 months

Ingredients : Other , Bortezomib

Application : Other, Cancer treatment

ZOLDONAT ZOLEDRONIC ACID INJECTION

ZOLDONAT ZOLEDRONIC ACID INJECTION

Dosage Form : Injection

Feature : Other, Ready to use, single dose vial

Shelf Life : 24 months

Ingredients : Other , Zoledronic Acid, excipients, sterile water for injection

Application : Other, Intravenous use only

HERTAB LAPATINIB TABLETS

HERTAB LAPATINIB TABLETS

Dosage Form : Tablets

Feature : Other, Targeted therapy, used for HER2 positive breast cancer

Shelf Life : 24 months

Ingredients : Other , Lapatinib

Application : Other, Pharmaceutical, oncology



Back to top